The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

Despite recent events, I believe we have reason to be hopeful, but I fully understand the bitterness that got us here. That’s ...

AstraZeneca and Daiichi Sankyo shared the pooled analysis behind the refiling of their TROP2 antibody-drug conjugate (ADC) ...

Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...

Employees at a local hospital in North Charleston gathered Thursday to support one of their patients undergoing treatment.

Wedding bells were ringing at Trident Medical Center this afternoon. A 76-year-old lung cancer patient got married at the ...

Every year, over 20 million people globally are diagnosed with cancer and close to 9.5 million people will reportedly succumb ...

WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and ...